Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
96 Leser
Artikel bewerten:
(0)

Research and Markets - Blood Glucose (SMBG) Market - Forecast and Global Analysis - Key Players are Abbott Laboratories, Bayer HealthCare, LifeScan & Roche Diagnostics

DUBLIN, Mar 29, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast - Global Analysis" report to their offering.

Research and Markets Logo

Self-monitoring of blood glucose is a very lucrative business with enormous market opportunity. With the rise in the number of cases of diabetes being recorded worldwide, it is necessary for patients around the world to have their blood glucose level continuously monitored to avoid the consequences of high glucose level like cardiovascular diseases, a blood disorder, blindness, kidney disorder and many other conditions.

SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The primary growth factors for the SMBG market is the increasing global diabetic population; increasing awareness among the diabetes population, increasing spending on healthcare, active reimbursement policies and the technological advancement aimed at minimal and non-invasive testing methods.

Key Highlights of the Report

  • United States, Russia and United Kingdom are the top three leading countries in the Global SMBG market accounting for over 60% market share in 2016.
  • China and India are the leading diabetic countries in the world.
  • China has the highest number of self-monitoring of blood glucose users.
  • Blood glucose test strips market is mainly dominated by developed countries. Blood glucose meter is the second leading product segment while lancet captures the least share of the SMBG market.
  • In 2014, Life Scan became the leading player in SMBG market.
  • In the SMBG segments, big players such as Roche and Abbott Laboratories are continuously losing its market share.

Companies Mentioned

  • Abbott Laboratories
  • Bayer HealthCare
  • LifeScan Inc
  • Roche Diagnostic

Key Topics Covered:

1. Executive Summary

2. Global Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

3. Global Self-Monitoring of Blood Glucose (SMBG) Market and Forecast

4. Global Self-Monitoring of Blood Glucose (SMBG) Market Share and Forecast

5. United States SMBG Users, Market and Forecast to 2021

6. Brazil SMBG Users, Market and Forecast to 2021

7. United Kingdom SMBG Users, Market and Forecast to 2021

8. Germany SMBG Users, Market and Forecast to 2021

9. Spain SMBG Users, Market and Forecast to 2021

10. Italy SMBG Users, Market and Forecast to 2021

11. Netherlands SMBG Users, Market and Forecast to 2021

12. Norway SMBG Users, Market and Forecast to 2021

13. Sweden SMBG Users, Market and Forecast to 2021

14. Switzerland SMBG Users, Market and Forecast to 2021

15. Russia SMBG Users, Market and Forecast to 2021

16. India SMBG Users, Market and Forecast to 2021

17. China SMBG Users, Market and Forecast to 2021

18. Thailand SMBG Users, Market and Forecast to 2021

19. Korea SMBG Users, Market and Forecast to 2021

20. Malaysia SMBG Users, Market and Forecast to 2021

21. Australia SMBG Users, Market and Forecast to 2021

22. Kuwait SMBG Users, Market and Forecast to 2021

23. Key Players Analysis

For more information about this report visit http://www.researchandmarkets.com/research/b2nkks/blood_glucose

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.